Mealey's (March 21, 2022, 1:06 PM EDT) -- WASHINGTON, D.C. — A final written decision by the Patent Trial and Appeal Board that all claims of a patented Boston Scientific Neuromodulation Corp. patent are invalid as obvious was not erroneous, the Federal Circuit U.S. Court of Appeals ruled March 18....